Micromem Technologies Inc. filings document a foreign issuer that reports under Form 20-F and furnishes current information on Form 6-K. The company's regulatory record includes news-release exhibits on gas-phase and liquid-phase sensor development, the nanowire field-effect transistor biochemical sensor project, and collaboration-related technology updates involving defense and university research partners.
Micromem's filings also include annual and interim consolidated financial statements, management's discussion and analysis, officer certifications, operating and financial results, shareholders' deficiency, capital-structure disclosures, and material-event reports. Certain Form 6-K reports are incorporated by reference into the company's Form F-3 registration statement, linking current disclosures to its securities-registration record.
Micromem Technologies Inc. filed a Form 6-K highlighting progress on its wearable gas sensing project. The company has engaged two engineering students from the University of Toronto to work with the university’s team under a collaborative research agreement with the Department of National Defence.
This phase focuses on software and hardware needed for low-power, wearable architectures that adapt Micromem’s ultra-high sensitivity nanowire gas-sensing technology for real-world, field use. The company anticipates this work will lead to functional wearable prototypes, followed by validation testing with defense stakeholders and potential commercial partners. Micromem reports 634,081,495 shares issued.
Micromem Technologies Inc. reports progress on its gas-phase sensor program under a collaborative research agreement with the Department of National Defence and the University of Toronto. The company is developing ultra-sensitive detection systems for wearable and portable platforms.
The sensing platform targets zeptofarad (10⁻²¹ farads) sensitivity, enabling detection of extremely small electrical changes when minute quantities of substances interact with the sensor. Potential uses include environmental monitoring, industrial safety, healthcare diagnostics, energy infrastructure monitoring, and defense applications.
Micromem is refining sensor architecture, signal processing, and system integration to support compact, low-power, wearable units aligned with military-grade field requirements. The company plans to evaluate application opportunities and strategic partnerships to move the technology toward military and commercial deployment. Shares issued total 626,013,781.
Micromem Technologies Inc. filed an update describing progress on its liquid-phase nanowire field-effect transistor (NWFET) biochemical sensor, developed under a collaboration with the University of Toronto and Canada’s Department of National Defence. The platform targets highly sensitive detection of biochemical agents for both defence and medical uses.
The liquid-phase sensor has demonstrated detection of clinically relevant biomarkers tied to acute inflammation and infectious disease, including Angiopoietin-1, streptavidin-linked assays, and TREM-1 at low concentration levels. These results support moving to the next development phase, focusing on further biomarker validation and completing microfluidic integration, while complementing Micromem’s parallel gas-phase program and expanding potential applications into point-of-care diagnostics.
Micromem Technologies Inc. reports unaudited IFRS results for the three months ended January 31, 2026, showing a net loss of $363,005 versus net income of $437,452 a year earlier. There was no commercial revenue; results were driven by operating expenses, interest on convertible debentures, stock-based compensation of $177,914, and fair-value remeasurements of warrants and derivatives.
Operating cash outflow was $229,527, leaving cash of $223,423. Total assets were $272,211 against total liabilities of $5,898,868, producing a shareholders’ deficit of $5,626,657 and a working capital deficiency of $5,647,659. The company discloses material uncertainties that cast substantial doubt on its ability to continue as a going concern and notes continued reliance on $4,536,762 of convertible debentures plus warrant and derivative liabilities.
Management highlights progress in its collaboration with the University of Toronto, Defence Research and Development Canada and NSERC on nanowire-based gas and liquid biochemical sensors, targeting sensitive industrial and medical applications. During the quarter Micromem raised $164,106 through equity private placements and issued new convertible debentures, and subsequent events include further debenture financings, repayments and share conversions.
Micromem Technologies Inc. filed its annual report for the year ended October 31, 2025, showing it remains a pre‑revenue company focused on sensor technology. The company reported a net loss of $668,749, a sharp improvement from $3,062,798 in 2024, but still prepares its financial statements on a going concern basis.
Working capital deficiency was $5,578,407 at October 31, 2025, with cash of $250,148 and total assets of $308,461. Shareholders’ deficiency stood at $5,603,266, and there were 616,090,414 common shares outstanding.
Micromem continues to have no operating revenue and funds operations through equity and debt. In 2025 it raised net proceeds of $560,498 from private placements and $562,000 from convertible debentures, while converting and repaying portions of existing bridge loans. The company entered a research collaboration with the University of Toronto and Canada’s Department of National Defence to develop nanowire-based gas and biochemical sensors, for which Micromem will own the resulting intellectual property.
Micromem Technologies Inc. filed audited consolidated financial statements showing a net loss of $668,749 for the year ended October 31, 2025, a substantial reduction from $3,062,798 in 2024. The company still has no commercial revenue and funds operations mainly through debt and equity issuances.
At October 31, 2025 Micromem reported cash of $250,148, total assets of $308,461 and total liabilities of $5,911,727, resulting in a shareholders’ deficiency of $5,603,266 and a working capital deficit of $5,578,407. Convertible debentures of $4,294,559, derivative liabilities of $421,409 and warrant liabilities of $753,660 weigh heavily on the balance sheet. The auditors and management highlight material uncertainties that cast substantial doubt on Micromem’s ability to continue as a going concern, noting the need for additional financing and successful commercialization of its sensor technology.
Micromem Technologies Inc. filed a Form 6-K that includes a corporate update outlining its strategic priorities for 2026. The company is advancing proprietary nanotechnology and sensor platforms, broadening from oil and gas into defence and industrial systems using an AI-powered nanowire technology base developed with Defence Research and Development Canada and the University of Toronto.
Micromem is focusing on intellectual property protection, performance benchmarking and refining nanowire-based sensors for defined end-use requirements, including a potential wearable biochemical sensor platform. It aims at dual-use applications so technologies designed for advanced defence systems can transition into commercial markets such as environmental monitoring, industrial output monitoring and border security.
Micromem Technologies Inc. has closed a non-brokered private placement, raising aggregate gross proceeds of approximately C$327,778. The company issued 6,555,555 units at C$0.05 per unit, with each unit consisting of one common share and one warrant exercisable at C$0.06 per share for one year. In total, 6,555,555 common shares and 6,555,555 warrants were issued, with all securities subject to a four-month hold period. No insiders participated and all subscribers are at arm's length. Micromem plans to use the net proceeds for working capital. The company reports that 622,645,969 shares were issued overall. The private placement remains subject to post-closing requirements of the Canadian Securities Exchange.
Micromem Technologies Inc. filed a Form 6-K as a foreign private issuer in January 2026. The filing states that the report is incorporated by reference into the company’s existing Form F-3 shelf registration statement, becoming part of that registration from the filing date. The 6-K also lists an attached news release dated January 14, 2026 as Exhibit 99.1.